Xenon Pharmaceuticals Inc. (XENE) › Total LiabilitiesXenon Pharmaceuticals Inc. (XENE) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2013: $30.37M2014: $14.64M2015: $2.92M2016: $3.59M2017: $10.19M2018: $19.13M2019: $55.72M2020: $17.83M2021: $21.97M2022: $32.65M2023: $36.88M2024: $43.24M2025: $51.40M$51.40M2013Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$51.40M+18.9%2024$43.24M+17.2%2023$36.88M+12.9%2022$32.65M+48.6%2021$21.97M+23.2%2020$17.83M-68.0%2019$55.72M+191.2%2018$19.13M+87.8%2017$10.19M+184.1%2016$3.59M+23.0%2015$2.92M-80.1%2014$14.64M-51.8%2013$30.37M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share